Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Microsoft
MSFT
|
$956M |
| 2 |
Ryanair
RYAAY
|
$678M |
| 3 |
Shopify
SHOP
|
$652M |
| 4 |
Sea Limited
SE
|
$499M |
| 5 |
Nu Holdings
NU
|
$330M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$2.25B |
| 2 |
Ginkgo Bioworks
DNA
|
$1.07B |
| 3 |
TSMC
TSM
|
$541M |
| 4 |
Tesla
TSLA
|
$428M |
| 5 |
Mercado Libre
MELI
|
$322M |
Sector Composition
| 1 | Consumer Discretionary | 32.31% |
| 2 | Technology | 26.39% |
| 3 | Communication Services | 14.86% |
| 4 | Healthcare | 11.39% |
| 5 | Financials | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
EOG Resources
EOG
$68.8B
| $5.67M | ﹤0.01% |
46,099
+1,891
| +4% | +$232K |
|
227
Codexis
CDXS
$246M
| $5.59M | ﹤0.01% |
1,813,800
-895,002
| -33% | -$2.76M |
|
228
EverQuote
EVER
$849M
| $5.57M | ﹤0.01% |
263,931
-160,252
| -38% | -$3.38M |
|
229
Albemarle Corp Depositary Shares
ALB.PRA
$1.73B
| $5.4M | ﹤0.01% |
120,000
| – | – |
|
230
Sutro Biopharma
STRO
$80.6M
| $5.26M | ﹤0.01% |
1,519,341
-329,410
| -18% | -$1.14M |
|
231
Medpace
MEDP
$13.4B
| $4.97M | ﹤0.01% |
14,876
+9,478
| +176% | +$3.16M |
|
232
Golub Capital BDC
GBDC
$3.97B
| $3.8M | ﹤0.01% |
251,639
-254,320
| -50% | -$3.84M |
|
233
ResMed
RMD
$40.2B
| $3.78M | ﹤0.01% |
15,500
-37,059
| -71% | -$9.05M |
|
234
Exelon
EXC
$44.1B
| $3.75M | ﹤0.01% |
92,534
-3,104
| -3% | -$126K |
|
235
Sixth Street Specialty
TSLX
$2.3B
| $3.65M | ﹤0.01% |
177,666
-232,388
| -57% | -$4.77M |
|
236
Veeva Systems
VEEV
$44.1B
| $3.22M | ﹤0.01% |
15,349
-34,805
| -69% | -$7.3M |
|
237
Ascendis Pharma
ASND
$11.8B
| $3.2M | ﹤0.01% |
21,403
-49,668
| -70% | -$7.42M |
|
238
CenterPoint Energy
CNP
$24.6B
| $2.32M | ﹤0.01% |
78,838
| – | – |
|
239
Southern Company
SO
$102B
| $2M | ﹤0.01% |
22,231
| – | – |
|
|
BSLK
240
Bolt Projects Holdings, Inc. Common Stock
BSLK
$11M
| $1.97M | ﹤0.01% |
+2,465,807
| New | +$1.97M |
|
241
Expensify
EXFY
$182M
| $1.82M | ﹤0.01% |
930,285
-157,120
| -14% | -$308K |
|
242
Cardlytics
CDLX
$54.3M
| $1.82M | ﹤0.01% |
567,396
-261,874
| -32% | -$838K |
|
243
Philip Morris
PM
$260B
| $1.65M | ﹤0.01% |
+13,612
| New | +$1.65M |
|
244
Ionis Pharmaceuticals
IONS
$9.16B
| $1.59M | ﹤0.01% |
39,581
-220,673
| -85% | -$8.84M |
|
|
CLLS
245
Cellectis
CLLS
$258M
| $1.49M | ﹤0.01% |
693,939
-13,691
| -2% | -$29.3K |
|
246
Equity Residential
EQR
$25.3B
| $1.47M | ﹤0.01% |
19,715
| – | – |
|
|
GOOS
247
Canada Goose Holdings
GOOS
$1.27B
| $1.44M | ﹤0.01% |
115,048
-4,173
| -4% | -$52.3K |
|
|
NYAX
248
Nayax
NYAX
$1.84B
| $1.28M | ﹤0.01% |
50,086
| – | – |
|
249
Consolidated Edison
ED
$35.4B
| $1.21M | ﹤0.01% |
11,628
| – | – |
|
250
Digital Realty Trust
DLR
$57.2B
| $1.11M | ﹤0.01% |
6,883
| – | – |
|